Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
2,977 rows where has_cryoEM = 0, has_known_aptamer = 0 and tier = "Tier 1.5" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total
surface_class 5
- B_cargo 1,593
- unknown 667
- A_surface 385
- A2_pm_peripheral 173
- A_assoc 159
tier 1
- Tier 1.5 · 2,977 ✖
has_known_aptamer 1
- - · 2,977 ✖
has_cryoEM 1
- - · 2,977 ✖
has_activation_state_pdb_pair 1
- 0 2,977
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P51795 | CLCN5 | H(+)/Cl(-) exchange transporter 5 | Tier 1.5 | 0.955 | 1 | A_surface | 2 | 80.62 | 0 | 0 | 0 | 0 | 1 | Dent disease type 1 | 0.850724240157394 | |||
| P25189 | MPZ | Myelin protein P0 | Tier 1.5 | 0.951 | 1 | A_surface | 2 | 81.69 | 0 | 0 | 0 | 0 | 1 | Charcot-Marie-Tooth disease type 1B | 0.8377022197539885 | |||
| P13473 | LAMP2 | Lysosome-associated membrane glycoprotein 2 | Tier 1.5 | 0.948 | 1 | A_surface | 2 | 83.19 | 0 | 0 | 0 | 0 | 1 | Glycogen Storage Disease Type 2b | 0.8273010649608126 | |||
| O94856 | NFASC | Neurofascin | Tier 1.5 | 0.933 | 1 | A_surface | 2 | 76.31 | 0 | 0 | 0 | 0 | 1 | neurodevelopmental disorder with central and peripheral motor dysfunction | 0.7782432580663833 | |||
| Q15746 | MYLK | Myosin light chain kinase, smooth muscle | Tier 1.5 | 0.93 | 1 | A_surface | 7 | 65.88 | 0 | 0 | 0 | 0 | 1 | aortic aneurysm, familial thoracic 7 | 0.7659842793171938 | |||
| Q02413 | DSG1 | Desmoglein-1 | Tier 1.5 | 0.92 | 1 | A_surface | 1 | 62.06 | 0 | 0 | 0 | 0 | 1 | severe dermatitis-multiple allergies-metabolic wasting syndrome | 0.7335328506238418 | |||
| Q13555 | CAMK2G | Calcium/calmodulin-dependent protein kinase type II subunit gamma | Tier 1.5 | 0.891 | 1 | A_surface | 2 | 78.38 | 0 | 0 | 0 | 0 | 1 | intellectual developmental disorder 59 | 0.6354497016986491 | |||
| Q92956 | TNFRSF14 | Tumor necrosis factor receptor superfamily member 14 | Tier 1.5 | 0.879 | 1 | A_surface | 8 | 79.94 | 0 | 0 | 0 | 0 | 1 | diffuse large B-cell lymphoma | 0.5983171413833771 | |||
| P01597 | IGKV1-39 | Immunoglobulin kappa variable 1-39 | Tier 1.5 | 0.876 | 1 | A_surface | 2 | 90.5 | 0 | 0 | 0 | 0 | 1 | cutaneous Leishmaniasis | 0.5868213846274001 | |||
| P01764 | IGHV3-23 | Immunoglobulin heavy variable 3-23 | Tier 1.5 | 0.876 | 1 | A_surface | 6 | 91.0 | 0 | 0 | 0 | 0 | 1 | cutaneous Leishmaniasis | 0.5868213846274001 | |||
| P23083 | IGHV1-2 | Immunoglobulin heavy variable 1-2 | Tier 1.5 | 0.876 | 1 | A_surface | 1 | 91.75 | 0 | 0 | 0 | 0 | 1 | cutaneous Leishmaniasis | 0.5868213846274001 | |||
| P01593 | IGKV1D-33 | Immunoglobulin kappa variable 1D-33 | Tier 1.5 | 0.876 | 1 | A_surface | 6 | 90.88 | 0 | 0 | 0 | 0 | 1 | cutaneous Leishmaniasis | 0.5868213846274001 | |||
| P06312 | IGKV4-1 | Immunoglobulin kappa variable 4-1 | Tier 1.5 | 0.876 | 1 | A_surface | 10 | 90.62 | 0 | 0 | 0 | 0 | 1 | cutaneous Leishmaniasis | 0.5868213846274001 | |||
| Q96D96 | HVCN1 | Voltage-gated hydrogen channel 1 | Tier 1.5 | 0.865 | 1 | A_surface | 2 | 69.75 | 0 | 0 | 0 | 0 | 1 | Joubert syndrome | 0.5504227269701596 | |||
| Q9P1W8 | SIRPG | Signal-regulatory protein gamma | Tier 1.5 | 0.864 | 1 | A_surface | 2 | 85.5 | 0 | 0 | 0 | 0 | 1 | type 1 diabetes mellitus | 0.5457344827318543 | |||
| O15155 | BET1 | BET1 homolog | Tier 1.5 | 0.864 | 1 | A_surface | 1 | 83.06 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.5468418315282804 | |||
| P34741 | SDC2 | Syndecan-2 | Tier 1.5 | 0.863 | 1 | A_surface | 1 | 60.84 | 0 | 0 | 0 | 0 | 1 | COVID-19 | 0.5422254875204983 | |||
| O00161 | SNAP23 | Synaptosomal-associated protein 23 | Tier 1.5 | 0.859 | 1 | A_surface | 2 | 82.12 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.5288361677964304 | |||
| P54756 | EPHA5 | Ephrin type-A receptor 5 | Tier 1.5 | 0.858 | 1 | A_surface | 2 | 79.38 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.5261379875719714 | |||
| Q9HCM2 | PLXNA4 | Plexin-A4 | Tier 1.5 | 0.856 | 1 | A_surface | 1 | 83.06 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.518371001420808 | |||
| P02462 | COL4A1 | Collagen alpha-1(IV) chain | Tier 1.5 | 0.854 | 1 | A_assoc | 4 | 48.47 | 0 | 0 | 0 | 0 | 1 | brain small vessel disease 1 with or without ocular anomalies | 0.84655287380359 | |||
| P15814 | IGLL1 | Immunoglobulin lambda-like polypeptide 1 | Tier 1.5 | 0.85 | 1 | A_surface | 3 | 75.06 | 0 | 0 | 0 | 0 | 1 | isolated agammaglobulinemia | 0.4996673834185043 | |||
| P18084 | ITGB5 | Integrin beta-5 | Tier 1.5 | 0.846 | 1 | A_surface | 3 | 82.19 | 0 | 0 | 0 | 0 | 1 | migraine disorder | 0.48652455084344876 | |||
| P22105 | TNXB | Tenascin-X | Tier 1.5 | 0.837 | 1 | A_assoc | 3 | 87.81 | 0 | 0 | 0 | 0 | 1 | Ehlers-Danlos syndrome due to tenascin-X deficiency | 0.7916412481554758 | |||
| A1L3X0 | ELOVL7 | Very long chain fatty acid elongase 7 | Tier 1.5 | 0.828 | 1 | A_surface | 1 | 89.75 | 0 | 0 | 0 | 0 | 1 | substance-related disorder | 0.4271436896798171 | |||
| Q92854 | SEMA4D | Semaphorin-4D | Tier 1.5 | 0.828 | 1 | A_surface | 2 | 80.81 | 0 | 0 | 0 | 0 | 1 | skin aging | 0.4259843235238637 | |||
| P20702 | ITGAX | Integrin alpha-X | Tier 1.5 | 0.825 | 1 | A_surface | 9 | 88.0 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.41708750879240836 | |||
| P08572 | COL4A2 | Collagen alpha-2(IV) chain | Tier 1.5 | 0.819 | 1 | A_assoc | 4 | 47.25 | 0 | 0 | 0 | 0 | 1 | porencephaly 2 | 0.7294975109351518 | |||
| P35080 | PFN2 | Profilin-2 | Tier 1.5 | 0.817 | 1 | A_surface | 1 | 95.5 | 0 | 0 | 0 | 0 | 1 | smoking initiation | 0.38873499449725424 | |||
| Q08554 | DSC1 | Desmocollin-1 | Tier 1.5 | 0.81 | 1 | A_surface | 2 | 76.75 | 0 | 0 | 0 | 0 | 1 | atopic eczema | 0.3674657640592667 | |||
| O95255 | ABCC6 | ATP-binding cassette sub-family C member 6 | Tier 1.5 | 0.809 | 1 | A_surface | 4 | 80.94 | 0 | 0 | 0 | 0 | 0 | Pseudoxanthoma elasticum | 0.864631668818611 | |||
| O75144 | ICOSLG | ICOS ligand | Tier 1.5 | 0.803 | 1 | A_surface | 2 | 82.56 | 0 | 0 | 0 | 0 | 1 | immunodeficiency 119 | 0.34184658238916177 | |||
| P30968 | GNRHR | Gonadotropin-releasing hormone receptor | Tier 1.5 | 0.799 | 1 | A_surface | 1 | 84.19 | 0 | 0 | 0 | 0 | 0 | hypogonadotropic hypogonadism | 0.83100005285263 | |||
| O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | Tier 1.5 | 0.795 | 1 | A_surface | 6 | 88.62 | 0 | 0 | 0 | 0 | 1 | Takayasu arteritis | 0.3170299762085396 | |||
| P29400 | COL4A5 | Collagen alpha-5(IV) chain | Tier 1.5 | 0.794 | 1 | A2_pm_peripheral | 2 | 48.12 | 0 | 0 | 0 | 0 | 1 | X-linked Alport syndrome | 0.8472963899466404 | |||
| Q14315 | FLNC | Filamin-C | Tier 1.5 | 0.791 | 1 | A2_pm_peripheral | 14 | 75.06 | 0 | 0 | 0 | 0 | 1 | hypertrophic cardiomyopathy 26 | 0.8363192336142512 | |||
| O43525 | KCNQ3 | Potassium voltage-gated channel subfamily KQT member 3 | Tier 1.5 | 0.789 | 1 | A_surface | 1 | 56.72 | 0 | 0 | 0 | 0 | 0 | Benign familial neonatal seizures | 0.7961763561533409 | |||
| P37023 | ACVRL1 | Activin receptor type-1-like | Tier 1.5 | 0.789 | 1 | A_surface | 7 | 82.0 | 0 | 0 | 0 | 0 | 0 | telangiectasia, hereditary hemorrhagic, type 2 | 0.7951167515831324 | |||
| Q13698 | CACNA1S | Voltage-dependent L-type calcium channel subunit alpha-1S | Tier 1.5 | 0.786 | 1 | A_surface | 2 | 71.81 | 0 | 0 | 0 | 0 | 0 | hypokalemic periodic paralysis, type 1 | 0.7869997029542154 | |||
| Q9Y6C2 | EMILIN1 | EMILIN-1 | Tier 1.5 | 0.786 | 1 | A_assoc | 2 | 62.91 | 0 | 0 | 0 | 0 | 1 | arterial tortuosity-bone fragility syndrome | 0.6185329512431467 | |||
| P49767 | VEGFC | Vascular endothelial growth factor C | Tier 1.5 | 0.785 | 1 | A_assoc | 4 | 73.19 | 0 | 0 | 0 | 0 | 1 | Milroy disease | 0.6170524106764851 | |||
| O75396 | SEC22B | Vesicle-trafficking protein SEC22b | Tier 1.5 | 0.783 | 1 | A_surface | 5 | 83.5 | 0 | 0 | 0 | 0 | 1 | inflammatory bowel disease | 0.27585917531110155 | |||
| O95630 | STAMBP | STAM-binding protein | Tier 1.5 | 0.782 | 1 | A2_pm_peripheral | 5 | 84.0 | 0 | 0 | 0 | 0 | 1 | microcephaly-capillary malformation syndrome | 0.8060251236043802 | |||
| Q8TDI8 | TMC1 | Transmembrane channel-like protein 1 | Tier 1.5 | 0.781 | 1 | A_surface | 1 | 76.88 | 0 | 0 | 0 | 0 | 0 | autosomal recessive nonsyndromic hearing loss 7 | 0.7694318181814068 | |||
| P12814 | ACTN1 | Alpha-actinin-1 | Tier 1.5 | 0.777 | 1 | A2_pm_peripheral | 4 | 85.25 | 0 | 0 | 0 | 0 | 1 | platelet-type bleeding disorder 15 | 0.7887662502912471 | |||
| Q9NUN7 | ACER3 | Alkaline ceramidase 3 | Tier 1.5 | 0.777 | 1 | A_surface | 2 | 93.19 | 0 | 0 | 0 | 0 | 0 | alkaline ceramidase 3 deficiency | 0.7575827142824458 | |||
| Q12983 | BNIP3 | BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 | Tier 1.5 | 0.773 | 1 | A_surface | 3 | 63.62 | 0 | 0 | 0 | 0 | 1 | hidradenitis | 0.24436077603455422 | |||
| Q9Y6J6 | KCNE2 | Potassium voltage-gated channel subfamily E member 2 | Tier 1.5 | 0.772 | 1 | A_surface | 1 | 78.25 | 0 | 0 | 0 | 0 | 0 | Romano-Ward syndrome | 0.739531738338193 | |||
| O14523 | C2CD2L | Phospholipid transfer protein C2CD2L | Tier 1.5 | 0.772 | 1 | A_surface | 1 | 63.94 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.23848230499510428 | |||
| O43914 | TYROBP | TYRO protein tyrosine kinase-binding protein | Tier 1.5 | 0.77 | 1 | A_surface | 5 | 64.62 | 0 | 0 | 0 | 0 | 0 | Nasu-Hakola disease | 0.7323368313860329 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;